Journey Medical Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
DERM Nasdaq 2830 journeymedicalcorp.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Journey Medical Corporation

Are Options Traders Betting on a Big Move in Journey Medical Stock? - Sep 21st, 2026 10:02 am
Journey Medical Corporation to Participate in September 2026 Investor Conferences - Sep 8th, 2026 2:05 pm
Papulopustular Rosacea Market Report Now Available, Covers 11 Countries Across North America, Europe, and Asia-Pacific, Profiling Galderma, Journey Medical, Dermata Therapeutics, and Dr. Reddy's Laboratories - Aug 31st, 2026 3:05 am
ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy? - Aug 25th, 2026 9:20 am
Journey Medical (DERM) Q2 2026 Earnings Call Transcript - Aug 19th, 2026 3:58 pm
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer - Aug 19th, 2026 2:05 pm
Journey Medical Corp (DERM) (Q2 2026) Earnings Call Highlights: Emrosi Surges 20% Sequentially, ... - Aug 12th, 2026 11:02 pm
Journey Medical Corporation Q2 2026 Earnings Call Summary - Aug 12th, 2026 7:04 pm
Fortress Biotech Q2 Earnings Call Highlights - Aug 12th, 2026 5:04 pm
Journey Medical Q2 Earnings Call Highlights - Aug 12th, 2026 5:04 pm
Here's What Key Metrics Tell Us About Journey Medical (DERM) Q2 Earnings - Aug 12th, 2026 4:30 pm
Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates - Aug 12th, 2026 3:40 pm
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - Aug 12th, 2026 2:01 pm
Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates - Aug 10th, 2026 7:10 am
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 - Aug 5th, 2026 6:30 am
Merck KGaA (MKKGY) Soars 5.3%: Is Further Upside Left in the Stock? - Jun 26th, 2026 7:00 am
Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes - Jun 24th, 2026 10:29 pm
How The Journey Medical (DERM) Investment Narrative Is Evolving With An Unchanged Valuation Target - Jun 3rd, 2026 4:07 pm
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference - May 19th, 2026 2:45 pm
Journey Medical Corporation Q1 2026 Earnings Call Summary - May 14th, 2026 6:25 pm